Serveur sur les données et bibliothèques médicales au Maghreb

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Investigation of New Inhibitors of UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) by Virtual Screening with Antibacterial Assessment.

Identifieur interne : 000170 ( Main/Corpus ); précédent : 000169; suivant : 000171

Investigation of New Inhibitors of UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) by Virtual Screening with Antibacterial Assessment.

Auteurs : Ilham Boulhissa ; Abdelouahab Chikhi ; Abderrahmane Bensegueni ; Mohammad A. Ghattas ; El H. Mokrani ; Sara Alrawashdeh ; Dana E E. Obaid

Source :

RBID : pubmed:32053077

Abstract

BACKGROUND

Considering the interesting role in the peptidoglycan biosynthesis pathway, the enzyme UDP-N-acetylglucosamine enolpyruvyl transferase is an attractive target to develop new antibacterial agents. It catalyzes the first key step of this pathway and its inhibition leads to bacterial cell death. Fosfomycin is known as the natural inhibitor of MurA.

OBJECTIVE

The study aimed to introduce new inhibitors of MurA by virtual screening of different chemical compounds libraries, and test the best scored "virtual hits" against three pathogenic bacteria: Escherichia coli, Bacillus subtilis and Staphylococcus aureus.

METHODS

A virtual screening of the structural analogues of fosfomycin downloaded from the Pub- Chem database was performed. Moreover, French National Chemical Library and ZINC database were also utilized to identify new structures different from fosfomycin. FlexX was the software used for this study. The antibacterial testing was divided into two methods: disk diffusion and broth dilution.

RESULTS

A set of virtual hits was found to have better energy score than that of fosfomycin, seven of them were tested in vitro. In addition, the disk diffusion method explored four compounds that exhibited antibacterial activity: CID-21680357 (fosfomycin analogue), AB-00005001, ZINC04658565, and ZINC901335. The testing was continued by broth dilution method for both compounds CID-21680357 and ZINC901335 to determine their minimum inhibitory concentrations, and ZINC901335 had the best value with 457μg/ml against Staphylococcus aureus.

CONCLUSION

Four compounds were found and proven in silico and in vitro to have antibacterial activity, namely CID-21680357, AB-00005001, ZINC04658565, and ZINC901335.


DOI: 10.2174/1573409916666200213124929
PubMed: 32053077

Links to Exploration step

pubmed:32053077

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Investigation of New Inhibitors of UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) by Virtual Screening with Antibacterial Assessment.</title>
<author>
<name sortKey="Boulhissa, Ilham" sort="Boulhissa, Ilham" uniqKey="Boulhissa I" first="Ilham" last="Boulhissa">Ilham Boulhissa</name>
<affiliation>
<nlm:affiliation>Laboratory of Applied Biochemistry, Department of Biochemistry and Cellular and Molecular Biology, Faculty of Natural and Life Sciences, University of Mentouri Brothers Constantine 1, Constantine, Algeria.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chikhi, Abdelouahab" sort="Chikhi, Abdelouahab" uniqKey="Chikhi A" first="Abdelouahab" last="Chikhi">Abdelouahab Chikhi</name>
<affiliation>
<nlm:affiliation>Laboratory of Applied Biochemistry, Department of Biochemistry and Cellular and Molecular Biology, Faculty of Natural and Life Sciences, University of Mentouri Brothers Constantine 1, Constantine, Algeria.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bensegueni, Abderrahmane" sort="Bensegueni, Abderrahmane" uniqKey="Bensegueni A" first="Abderrahmane" last="Bensegueni">Abderrahmane Bensegueni</name>
<affiliation>
<nlm:affiliation>Laboratory of Applied Biochemistry, Department of Biochemistry and Cellular and Molecular Biology, Faculty of Natural and Life Sciences, University of Mentouri Brothers Constantine 1, Constantine, Algeria.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ghattas, Mohammad A" sort="Ghattas, Mohammad A" uniqKey="Ghattas M" first="Mohammad A" last="Ghattas">Mohammad A. Ghattas</name>
<affiliation>
<nlm:affiliation>College of Pharmacy, Al Ain University of Science and Technology, Al Ain, United Arab Emirates.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mokrani, El H" sort="Mokrani, El H" uniqKey="Mokrani E" first="El H" last="Mokrani">El H. Mokrani</name>
<affiliation>
<nlm:affiliation>Laboratory of Applied Biochemistry, Department of Biochemistry and Cellular and Molecular Biology, Faculty of Natural and Life Sciences, University of Mentouri Brothers Constantine 1, Constantine, Algeria.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Alrawashdeh, Sara" sort="Alrawashdeh, Sara" uniqKey="Alrawashdeh S" first="Sara" last="Alrawashdeh">Sara Alrawashdeh</name>
<affiliation>
<nlm:affiliation>College of Pharmacy, Al Ain University of Science and Technology, Al Ain, United Arab Emirates.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Obaid, Dana E E" sort="Obaid, Dana E E" uniqKey="Obaid D" first="Dana E E" last="Obaid">Dana E E. Obaid</name>
<affiliation>
<nlm:affiliation>College of Pharmacy, Al Ain University of Science and Technology, Al Ain, United Arab Emirates.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:32053077</idno>
<idno type="pmid">32053077</idno>
<idno type="doi">10.2174/1573409916666200213124929</idno>
<idno type="wicri:Area/Main/Corpus">000170</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000170</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Investigation of New Inhibitors of UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) by Virtual Screening with Antibacterial Assessment.</title>
<author>
<name sortKey="Boulhissa, Ilham" sort="Boulhissa, Ilham" uniqKey="Boulhissa I" first="Ilham" last="Boulhissa">Ilham Boulhissa</name>
<affiliation>
<nlm:affiliation>Laboratory of Applied Biochemistry, Department of Biochemistry and Cellular and Molecular Biology, Faculty of Natural and Life Sciences, University of Mentouri Brothers Constantine 1, Constantine, Algeria.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chikhi, Abdelouahab" sort="Chikhi, Abdelouahab" uniqKey="Chikhi A" first="Abdelouahab" last="Chikhi">Abdelouahab Chikhi</name>
<affiliation>
<nlm:affiliation>Laboratory of Applied Biochemistry, Department of Biochemistry and Cellular and Molecular Biology, Faculty of Natural and Life Sciences, University of Mentouri Brothers Constantine 1, Constantine, Algeria.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bensegueni, Abderrahmane" sort="Bensegueni, Abderrahmane" uniqKey="Bensegueni A" first="Abderrahmane" last="Bensegueni">Abderrahmane Bensegueni</name>
<affiliation>
<nlm:affiliation>Laboratory of Applied Biochemistry, Department of Biochemistry and Cellular and Molecular Biology, Faculty of Natural and Life Sciences, University of Mentouri Brothers Constantine 1, Constantine, Algeria.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ghattas, Mohammad A" sort="Ghattas, Mohammad A" uniqKey="Ghattas M" first="Mohammad A" last="Ghattas">Mohammad A. Ghattas</name>
<affiliation>
<nlm:affiliation>College of Pharmacy, Al Ain University of Science and Technology, Al Ain, United Arab Emirates.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mokrani, El H" sort="Mokrani, El H" uniqKey="Mokrani E" first="El H" last="Mokrani">El H. Mokrani</name>
<affiliation>
<nlm:affiliation>Laboratory of Applied Biochemistry, Department of Biochemistry and Cellular and Molecular Biology, Faculty of Natural and Life Sciences, University of Mentouri Brothers Constantine 1, Constantine, Algeria.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Alrawashdeh, Sara" sort="Alrawashdeh, Sara" uniqKey="Alrawashdeh S" first="Sara" last="Alrawashdeh">Sara Alrawashdeh</name>
<affiliation>
<nlm:affiliation>College of Pharmacy, Al Ain University of Science and Technology, Al Ain, United Arab Emirates.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Obaid, Dana E E" sort="Obaid, Dana E E" uniqKey="Obaid D" first="Dana E E" last="Obaid">Dana E E. Obaid</name>
<affiliation>
<nlm:affiliation>College of Pharmacy, Al Ain University of Science and Technology, Al Ain, United Arab Emirates.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Current computer-aided drug design</title>
<idno type="eISSN">1875-6697</idno>
<imprint>
<date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>Considering the interesting role in the peptidoglycan biosynthesis pathway, the enzyme UDP-N-acetylglucosamine enolpyruvyl transferase is an attractive target to develop new antibacterial agents. It catalyzes the first key step of this pathway and its inhibition leads to bacterial cell death. Fosfomycin is known as the natural inhibitor of MurA.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>OBJECTIVE</b>
</p>
<p>The study aimed to introduce new inhibitors of MurA by virtual screening of different chemical compounds libraries, and test the best scored "virtual hits" against three pathogenic bacteria: Escherichia coli, Bacillus subtilis and Staphylococcus aureus.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>A virtual screening of the structural analogues of fosfomycin downloaded from the Pub- Chem database was performed. Moreover, French National Chemical Library and ZINC database were also utilized to identify new structures different from fosfomycin. FlexX was the software used for this study. The antibacterial testing was divided into two methods: disk diffusion and broth dilution.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>A set of virtual hits was found to have better energy score than that of fosfomycin, seven of them were tested in vitro. In addition, the disk diffusion method explored four compounds that exhibited antibacterial activity: CID-21680357 (fosfomycin analogue), AB-00005001, ZINC04658565, and ZINC901335. The testing was continued by broth dilution method for both compounds CID-21680357 and ZINC901335 to determine their minimum inhibitory concentrations, and ZINC901335 had the best value with 457μg/ml against Staphylococcus aureus.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSION</b>
</p>
<p>Four compounds were found and proven in silico and in vitro to have antibacterial activity, namely CID-21680357, AB-00005001, ZINC04658565, and ZINC901335.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="In-Process" Owner="NLM">
<PMID Version="1">32053077</PMID>
<DateRevised>
<Year>2021</Year>
<Month>06</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1875-6697</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>17</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2021</Year>
</PubDate>
</JournalIssue>
<Title>Current computer-aided drug design</Title>
<ISOAbbreviation>Curr Comput Aided Drug Des</ISOAbbreviation>
</Journal>
<ArticleTitle>Investigation of New Inhibitors of UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) by Virtual Screening with Antibacterial Assessment.</ArticleTitle>
<Pagination>
<MedlinePgn>214-224</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2174/1573409916666200213124929</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Considering the interesting role in the peptidoglycan biosynthesis pathway, the enzyme UDP-N-acetylglucosamine enolpyruvyl transferase is an attractive target to develop new antibacterial agents. It catalyzes the first key step of this pathway and its inhibition leads to bacterial cell death. Fosfomycin is known as the natural inhibitor of MurA.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The study aimed to introduce new inhibitors of MurA by virtual screening of different chemical compounds libraries, and test the best scored "virtual hits" against three pathogenic bacteria: Escherichia coli, Bacillus subtilis and Staphylococcus aureus.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A virtual screening of the structural analogues of fosfomycin downloaded from the Pub- Chem database was performed. Moreover, French National Chemical Library and ZINC database were also utilized to identify new structures different from fosfomycin. FlexX was the software used for this study. The antibacterial testing was divided into two methods: disk diffusion and broth dilution.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A set of virtual hits was found to have better energy score than that of fosfomycin, seven of them were tested in vitro. In addition, the disk diffusion method explored four compounds that exhibited antibacterial activity: CID-21680357 (fosfomycin analogue), AB-00005001, ZINC04658565, and ZINC901335. The testing was continued by broth dilution method for both compounds CID-21680357 and ZINC901335 to determine their minimum inhibitory concentrations, and ZINC901335 had the best value with 457μg/ml against Staphylococcus aureus.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Four compounds were found and proven in silico and in vitro to have antibacterial activity, namely CID-21680357, AB-00005001, ZINC04658565, and ZINC901335.</AbstractText>
<CopyrightInformation>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Boulhissa</LastName>
<ForeName>Ilham</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Applied Biochemistry, Department of Biochemistry and Cellular and Molecular Biology, Faculty of Natural and Life Sciences, University of Mentouri Brothers Constantine 1, Constantine, Algeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chikhi</LastName>
<ForeName>Abdelouahab</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Applied Biochemistry, Department of Biochemistry and Cellular and Molecular Biology, Faculty of Natural and Life Sciences, University of Mentouri Brothers Constantine 1, Constantine, Algeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bensegueni</LastName>
<ForeName>Abderrahmane</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Applied Biochemistry, Department of Biochemistry and Cellular and Molecular Biology, Faculty of Natural and Life Sciences, University of Mentouri Brothers Constantine 1, Constantine, Algeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ghattas</LastName>
<ForeName>Mohammad A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>College of Pharmacy, Al Ain University of Science and Technology, Al Ain, United Arab Emirates.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mokrani</LastName>
<ForeName>El H</ForeName>
<Initials>EH</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Applied Biochemistry, Department of Biochemistry and Cellular and Molecular Biology, Faculty of Natural and Life Sciences, University of Mentouri Brothers Constantine 1, Constantine, Algeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alrawashdeh</LastName>
<ForeName>Sara</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>College of Pharmacy, Al Ain University of Science and Technology, Al Ain, United Arab Emirates.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Obaid</LastName>
<ForeName>Dana E E</ForeName>
<Initials>DEE</Initials>
<AffiliationInfo>
<Affiliation>College of Pharmacy, Al Ain University of Science and Technology, Al Ain, United Arab Emirates.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United Arab Emirates</Country>
<MedlineTA>Curr Comput Aided Drug Des</MedlineTA>
<NlmUniqueID>101265750</NlmUniqueID>
<ISSNLinking>1573-4099</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">FlexX</Keyword>
<Keyword MajorTopicYN="N">MurA</Keyword>
<Keyword MajorTopicYN="N">antibacterial agents</Keyword>
<Keyword MajorTopicYN="N">fosfomycin</Keyword>
<Keyword MajorTopicYN="N">in silico.</Keyword>
<Keyword MajorTopicYN="N">virtual screening</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2019</Year>
<Month>10</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>01</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>01</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>2</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>2</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>2</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32053077</ArticleId>
<ArticleId IdType="pii">CAD-EPUB-104494</ArticleId>
<ArticleId IdType="doi">10.2174/1573409916666200213124929</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MaghrebDataLibMedV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000170 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000170 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MaghrebDataLibMedV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32053077
   |texte=   Investigation of New Inhibitors of UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) by Virtual Screening with Antibacterial Assessment.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32053077" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MaghrebDataLibMedV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Jun 17 16:21:50 2021. Site generation: Thu Jun 17 21:51:18 2021